• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莫桑比克结核病患者慢性肺损伤的发展及相关风险。

Development of chronic lung impairment in Mozambican TB patients and associated risks.

机构信息

Instituto Nacional de Saúde (INS), Maputo, Mozambique.

Center for International Health - CIHLMU, Munich, Germany.

出版信息

BMC Pulm Med. 2020 May 7;20(1):127. doi: 10.1186/s12890-020-1167-1.

DOI:10.1186/s12890-020-1167-1
PMID:32381002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7203866/
Abstract

BACKGROUND

Pulmonary tuberculosis (PTB) is frequently associated with chronic respiratory impairment despite microbiological cure. There are only a few clinical research studies that describe the course, type and severity as well as associated risk factors for lung impairment (LI) in TB patients.

METHODS

A prospective cohort study was conducted at TB Research Clinic of Instituto Nacional de Saúde in Mavalane, Maputo, from June 2014 to June 2016. PTB patients were prospectively enrolled and followed for 52 weeks after TB diagnosis. Lung function was evaluated by spirometry at 8, 26 and 52 weeks after TB treatment initiation, and spirometric values of below the lower limit of normality were considered as LI. Descriptive statistical analysis was performed to summarize the proportion of patients with different lung outcomes at week 52, including type and severity of LI. Risk factors were analysed using multinomial regression analysis.

RESULTS

A total of 69 PTB patients were enrolled, of which 62 had a valid spirometry result at week 52 after TB treatment start. At week 8, 26 and 52, the proportion of patients with LI was 78, 68.9 and 64.5%, respectively, and 35.5% had moderate or severe LI at week 52. The majority of patients with LI suffered from pulmonary restriction. Female sex, low haemoglobin and heavy smoking were significantly associated with LI.

CONCLUSION

Moderate or severe LI can be observed in a third of cured TB patients. Further research is urgently needed to gain deeper insight into the characteristics of post TB LI, the causal pathways and potential treatment strategies.

摘要

背景

尽管结核分枝杆菌(PTB)已得到微生物学治愈,但仍常伴有慢性呼吸损害。仅有少数临床研究描述了结核病患者肺部损害(LI)的病程、类型和严重程度以及相关的危险因素。

方法

本前瞻性队列研究于 2014 年 6 月至 2016 年 6 月在马普托的莫桑比克国家卫生研究院结核病研究诊所进行。PTB 患者前瞻性入组,并在 TB 诊断后 52 周内进行随访。在 TB 治疗开始后 8、26 和 52 周,通过肺量计评估肺功能,将低于正常值下限的肺量计值定义为 LI。采用描述性统计分析总结第 52 周时不同肺部结局患者的比例,包括 LI 的类型和严重程度。采用多项回归分析评估危险因素。

结果

共纳入 69 例 PTB 患者,其中 62 例在 TB 治疗开始后 52 周时具有有效的肺量计结果。在第 8、26 和 52 周,LI 患者的比例分别为 78%、68.9%和 64.5%,第 52 周时 35.5%的患者有中重度 LI。大多数 LI 患者存在肺部受限。女性、低血红蛋白和重度吸烟与 LI 显著相关。

结论

三分之一治愈的 TB 患者可出现中重度 LI。迫切需要进一步研究以深入了解 TB 后 LI 的特征、因果途径和潜在治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/7203866/a5cbeb49f4a8/12890_2020_1167_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/7203866/1193b41915aa/12890_2020_1167_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/7203866/2e4502eea35f/12890_2020_1167_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/7203866/545383ff5e9d/12890_2020_1167_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/7203866/a5cbeb49f4a8/12890_2020_1167_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/7203866/1193b41915aa/12890_2020_1167_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/7203866/2e4502eea35f/12890_2020_1167_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/7203866/545383ff5e9d/12890_2020_1167_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/7203866/a5cbeb49f4a8/12890_2020_1167_Fig4_HTML.jpg

相似文献

1
Development of chronic lung impairment in Mozambican TB patients and associated risks.莫桑比克结核病患者慢性肺损伤的发展及相关风险。
BMC Pulm Med. 2020 May 7;20(1):127. doi: 10.1186/s12890-020-1167-1.
2
TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocol.结核后疾病:肺结核长期医疗和社会后遗症的发生率、发病机制和危险因素——一项研究方案。
BMC Pulm Med. 2019 Jan 7;19(1):4. doi: 10.1186/s12890-018-0777-3.
3
Changes in respiratory function impairment following the treatment of severe pulmonary tuberculosis - limitations for the underlying COPD detection.重症肺结核治疗后呼吸功能损害的变化——对潜在慢性阻塞性肺疾病检测的局限性
Int J Chron Obstruct Pulmon Dis. 2016 Jun 16;11:1307-16. doi: 10.2147/COPD.S106875. eCollection 2016.
4
Post-tuberculous lung function impairment in a tuberculosis reference clinic in Cameroon.喀麦隆一家结核病诊疗所中结核后肺功能损害情况
Respir Med. 2016 May;114:67-71. doi: 10.1016/j.rmed.2016.03.007. Epub 2016 Mar 11.
5
Spirometric abnormalities following treatment for pulmonary tuberculosis in Ilorin, Nigeria.尼日利亚伊洛林肺结核治疗后的肺功能异常
Niger Postgrad Med J. 2020 Jul-Sep;27(3):163-170. doi: 10.4103/npmj.npmj_18_20.
6
Adjunctive N-Acetylcysteine and Lung Function in Pulmonary Tuberculosis.辅助用 N-乙酰半胱氨酸与肺结核的肺功能。
NEJM Evid. 2024 Sep;3(9):EVIDoa2300332. doi: 10.1056/EVIDoa2300332. Epub 2024 Aug 27.
7
Spirometry results after treatment for pulmonary tuberculosis: comparison between patients with and without previous lung disease: a multicenter study.肺结核治疗后的肺功能检查结果:有和无既往肺部疾病患者的比较:一项多中心研究。
J Bras Pneumol. 2020 Mar 2;46(2):e20180198. doi: 10.36416/1806-3756/e20180198. eCollection 2020.
8
Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-implementation study protocol.在莫桑比克乔奎医院国家结核病控制项目中,对青少年和成年结核病后肺部疾病(PTLD)进行肺功能筛查的实施:一项混合 III 型有效性实施研究方案。
BMC Pulm Med. 2024 Oct 10;24(1):502. doi: 10.1186/s12890-024-03329-7.
9
Pulmonary functions' assessment in post-tuberculosis cases by spirometry: Obstructive pattern is predominant and needs cautious evaluation in all treated cases irrespective of symptoms.
Int J Mycobacteriol. 2018 Apr-Jun;7(2):128-133. doi: 10.4103/ijmy.ijmy_56_18.
10
Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis.抗微生物化疗对重症肺结核患者肺功能参数及促炎指标的影响
Eur Respir J. 1998 Aug;12(2):351-6. doi: 10.1183/09031936.98.12020351.

引用本文的文献

1
Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials.在结核病药物试验中纳入以患者为中心的非微生物学终点指标和生物标志物。
Front Antibiot. 2025 May 22;4:1570989. doi: 10.3389/frabi.2025.1570989. eCollection 2025.
2
Lung function of tuberculosis patients after completion of treatment in Sidama, South Ethiopia.埃塞俄比亚南部锡达马地区结核病患者治疗结束后的肺功能
Front Med (Lausanne). 2025 Mar 18;12:1451861. doi: 10.3389/fmed.2025.1451861. eCollection 2025.
3
Risk factors associated with post-tuberculosis sequelae: a systematic review and meta-analysis.

本文引用的文献

1
Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010-15: a population-based, longitudinal study.2010-2015 年巴西圣保罗州新诊断肺结核患者的长期生存和死因特异性死亡率:一项基于人群的纵向研究。
Lancet Infect Dis. 2020 Jan;20(1):123-132. doi: 10.1016/S1473-3099(19)30518-3. Epub 2019 Oct 31.
2
The long shadow post-tuberculosis.肺结核的长期影响。
Lancet Infect Dis. 2019 Nov;19(11):1170-1171. doi: 10.1016/S1473-3099(19)30564-X.
3
Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV (PURE): an international, community-based cohort study.
与肺结核后遗症相关的危险因素:一项系统评价和荟萃分析。
EClinicalMedicine. 2024 Oct 21;77:102898. doi: 10.1016/j.eclinm.2024.102898. eCollection 2024 Nov.
4
Pathogenesis of Post-Tuberculosis Lung Disease: Defining Knowledge Gaps and Research Priorities at the Second International Post-Tuberculosis Symposium.肺结核后肺部疾病的发病机制:第二届国际肺结核后研讨会定义知识空白和研究重点。
Am J Respir Crit Care Med. 2024 Oct 15;210(8):979-993. doi: 10.1164/rccm.202402-0374SO.
5
Performance of spirometry assessment at TB diagnosis.在结核病诊断中进行肺功能评估的性能。
Int J Tuberc Lung Dis. 2023 Aug 1;27(11):850-857. doi: 10.5588/ijtld.23.0040.
6
Effect of TB Treatment on Neutrophil-Derived Soluble Inflammatory Mediators in TB Patients with and without HIV Coinfection.结核病治疗对合并或未合并HIV感染的结核病患者中性粒细胞衍生的可溶性炎症介质的影响。
Pathogens. 2023 Jun 1;12(6):794. doi: 10.3390/pathogens12060794.
7
Residual respiratory disability after successful treatment of pulmonary tuberculosis: a systematic review and meta-analysis.肺结核成功治疗后的残余呼吸功能障碍:一项系统评价和荟萃分析。
EClinicalMedicine. 2023 May 8;59:101979. doi: 10.1016/j.eclinm.2023.101979. eCollection 2023 May.
8
Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people.肺结核后肺损伤:来自 14621 人的肺活量测定数据的系统评价和荟萃分析。
Eur Respir Rev. 2023 Apr 19;32(168). doi: 10.1183/16000617.0221-2022. Print 2023 Jun 30.
9
Magnitude and factors associated with post-tuberculosis lung disease in low- and middle-income countries: A systematic review and meta-analysis.低收入和中等收入国家结核病后肺部疾病的严重程度及相关因素:一项系统评价和荟萃分析。
PLOS Glob Public Health. 2022 Dec 20;2(12):e0000805. doi: 10.1371/journal.pgph.0000805. eCollection 2022.
10
Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy.血 C 反应蛋白浓度的降低补充了抗结核治疗患者痰细菌负荷的清除。
Front Immunol. 2022 Sep 16;13:1005692. doi: 10.3389/fimmu.2022.1005692. eCollection 2022.
FEV 受损个体的死亡率和心血管及呼吸道发病率(纯粹研究):一项国际社区为基础的队列研究。
Lancet Glob Health. 2019 May;7(5):e613-e623. doi: 10.1016/S2214-109X(19)30070-1.
4
Prevalence of lung function impairment in cured pulmonary tuberculosis patients in Cotonou, Benin.贝宁科托努治愈肺结核患者的肺功能损害患病率。
Int J Tuberc Lung Dis. 2019 Feb 1;23(2):195-202. doi: 10.5588/ijtld.18.0234.
5
The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy.肺结核中肺实质损伤的免疫机制及宿主导向治疗的作用
Front Microbiol. 2018 Oct 30;9:2603. doi: 10.3389/fmicb.2018.02603. eCollection 2018.
6
Predicting tuberculosis relapse in patients treated with the standard 6-month regimen: an individual patient data meta-analysis.预测接受标准 6 个月疗程治疗的患者结核病复发:一项个体患者数据荟萃分析。
Thorax. 2019 Mar;74(3):291-297. doi: 10.1136/thoraxjnl-2017-211120. Epub 2018 Nov 12.
7
International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review.关于肺结核后慢性肺部疾病的国际研究与指南:一项系统的范围综述
BMJ Glob Health. 2018 Jul 23;3(4):e000745. doi: 10.1136/bmjgh-2018-000745. eCollection 2018.
8
Pulmonary functions' assessment in post-tuberculosis cases by spirometry: Obstructive pattern is predominant and needs cautious evaluation in all treated cases irrespective of symptoms.
Int J Mycobacteriol. 2018 Apr-Jun;7(2):128-133. doi: 10.4103/ijmy.ijmy_56_18.
9
Tuberculosis and lung damage: from epidemiology to pathophysiology.结核病与肺部损伤:从流行病学到病理生理学。
Eur Respir Rev. 2018 Feb 28;27(147). doi: 10.1183/16000617.0077-2017. Print 2018 Mar 31.
10
Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement.肺功能报告标准化的建议。美国胸科学会技术声明。
Am J Respir Crit Care Med. 2017 Dec 1;196(11):1463-1472. doi: 10.1164/rccm.201710-1981ST.